laquinimod

Active Bio, Teva’s laquinimod fails once more, in Huntington’s

Active Biotech and Teva delivered more bad news from their clinical development of laquinimod, this time from a phase 2 trial in Huntington’s disease.

Conor Hale Jul 31, 2018 11:15am

Active Bio and Teva’s laquinimod strikes out in MS again

Dec 1, 2017 10:53am